Zai Lab Ltd (NAS:ZLAB)
$ 20.16 0.15 (0.75%) Market Cap: 1.98 Bil Enterprise Value: 1.42 Bil PE Ratio: 0 PB Ratio: 2.57 GF Score: 71/100

Zai Lab Ltd at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 02:00PM GMT
Release Date Price: $58.56 (+6.32%)
Anupam Rama
JPMorgan Chase & Co, Research Division - VP and Analyst

Welcome, everyone to the 40th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analyst here at JPMorgan. I'm joined by Priyanka Grover, [Malcom] Kuno and [Campbell] Smith from the team. Our next presenting company is Zai Lab, presenting on behalf of the company, we have CEO, Samantha Du. I want to remind all the attendees to use the ask a question feature in the portal and I would be happy to ask your question on your behalf.

With that, Samantha, take it away.

Ying Du
Zai Lab Limited - Founder, Chairperson & CEO

Thank you, Anupam, and good morning, everyone. It's great pleasure to be with you today. Slide #2 is our safe harbor slide. Now let's turn to Slide #3 please. I would like to begin by telling you who we are at Zai Lab, have been a drug hunter for over 30 years, first in the US, the largest drug market, now in China, the second largest and fast-growing market. In the last 20 years have been involved in a transformative

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot